GlassScriptPhysician profile
David W Strathern
NPI 1407816507
$14,125.53
in general payments reported to CMS, 2019-2025
33 companies · $340 in 2025
The $340 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,027 · 2020: $6,759 · 2021: $201 · 2022: $809 · 2023: $342 · 2024: $4,648 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Food and Beverage: $1,329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Food and Beverage | $1,329.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,399.60 | 2019-2024 | Da Vinci Surgical System |
| Boston Scientific Corporation | $281.16 | 2024-2025 | Spyglass Discover |
| Conmed Corporation | $167.57 | 2022 | |
| W. L. Gore & Associates, INC. | $160.47 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $124.35 | 2021-2024 | Andexxa |
| Smith+Nephew, INC. | $119.52 | 2019-2024 | Grafix Pl, Collagenase Santyl, Stravix |
| Penumbra, INC. | $91.32 | 2021 | |
| Molli Surgical (US) INC | $64.36 | 2023 | |
| Endogastric Solutions, INC | $57.50 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $55.88 | 2024-2025 | Keytruda, Lynparza |
| Polynovo North America LLC | $54.98 | 2024 | Novosorb Btm |
| Ferring Pharmaceuticals INC. | $42.48 | 2023-2024 | Rebyota |
| Eagle Pharmaceuticals, INC. | $41.00 | 2023-2024 | |
| Davol INC. | $39.68 | 2024 | Phasix Mesh |
| Aroa Biosurgery Incorporated | $36.67 | 2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $36.17 | 2022 | |
| Lemaitre Vascular, INC. | $33.72 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $33.56 | 2022-2025 | Exparel |
| Medtronic, INC. | $33.48 | 2024-2025 | Progrip, Interstim |
| Osiris Therapeutics INC. | $32.99 | 2019 | |
| Merit Medical Systems INC | $30.10 | 2024-2025 | Savi Scout |
| Acera Surgical, INC. | $21.84 | 2025 | Restrata Wound Matrix |
| Shire North American Group INC | $21.77 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.44 | 2024 | Eohilia |
| Medela LLC | $15.88 | 2022 | |
| Misonix INC | $15.60 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $15.26 | 2025 | |
| Kci USA, INC. | $15.17 | 2022 | |
| Octapharma USA, INC. | $14.72 | 2025 | Fibryga |
| Kerecis Limited | $14.24 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Solventum Corporation | $13.70 | 2025 | Prevena |
| Abbvie INC. | $12.79 | 2023 | Dalvance |
| Thd America, INC. | $8.56 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Strathern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.